A new analysis finds that a notable portion of treatment guidelines issued in recent years by medical societies and government agencies for combating mild depression were compiled by individuals with financial conflicts of interest or lacked other safeguards to ensure impartiality.

Of 172 people who participated in 14 guidelines committees, 18 percent had ties to drug makers that sell antidepressants, and some had connections to more than one company. Five guidelines, meanwhile, recommended antidepressants as a first-line treatment for mild depression, and four of those — or 80 percent — had panelists with some type of financial connection, according to the analysis in Psychotherapy and Psychosomatics.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Most antidepressants are prescribed by primary care physicians most of whom don’t know the first thing about psychopharmacology. The patients often wind up seeing the shrink due to medication mismanagemen by the idiot GP who produces an iatrogenic serotoninergic crisis because they were unaware of the taper guidelines for SSRI’s.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy